Irreversible Electroporation for the Treatment of Pediatric Adenotonsillar Hypertrophy
Journal of Clinical Medicine · 02.07.2026 · 15 (13) · 5189
DOI: 10.3390/jcm15135189 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Clinical Medicine, online erschienen am 02.07.2026. Verfasst von Ulugbek Khasanov und 6 weiteren Autor:innen. Beteiligte Einrichtung: Republican Specialized Scientific and Practical Center of Otorhinolaryngology and Head and Neck Diseases, Tashkent 100084, Uzbekistan. Die Arbeit nennt 16 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Entire Medical Inc..
Abstract (Originalsprache)
Background/Objectives: Irreversible electroporation (IRE) is a non-thermal tissue ablation technology, offering potential advantages such as reductions in pain, bleeding, and procedural time. With this study, we aimed to evaluate the safety and efficacy of IRE for the treatment of adenotonsillar hypertrophy in pediatric patients.
Methods
In this prospective, two-center, interventional case series, we enrolled 31 children aged 3–13 years with adenotonsillar hypertrophy and upper airway obstruction. All procedures were performed under general anesthesia. IRE was applied to the tonsils and adenoids using the ENTire™ system. Postoperative pain was recorded daily for seven days using the Parent’s Postoperative Pain Measure. Disease-specific quality of life was assessed at baseline and three months post-procedure using the Obstructive Sleep Apnea questionnaire (OSA-18). Tonsillar size was graded according to the Brodsky Scale.
Results
The mean procedure time was 10:40 ± 03:40, and there was no intraoperative or postoperative bleeding. Patients were discharged on the day of the procedure. The postoperative pain on day 1 was ranked as 3.5 ± 1.5 and resolved completely in all patients by day 7. From baseline to 3 months, the mean OSA-18 decreased from 66.4 ± 14.9 to 24.6 ± 9.9 (Wilcoxon signed-rank test p-value of
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Republican Specialized Scientific and Practical Center of Otorhinolaryngology and Head and Neck Diseases, Tashkent 100084, Uzbekistan.
- "M. S. Curie" Emergency Clinical Hospital for Children, 077120 Bucharest, Romania.
- ENT Clinic, University of Siena, 53100 Siena, Italy.
- Department Clinical Sciences and Translational Medicine, University of Rome "Tor Vergata", 00133 Roma, Italy.
- Department of Otolaryngology Head and Neck Surgery, Tel Aviv Sourasky University Medical Center, Gray Faculty of Medical and Health Sciences, Tel-Aviv University, Tel-Aviv 6997801, Israel.
ORCID-Profile: Desiderio Passali, Ari DeRowe
Förderung
- Entire Medical Inc.
Zitieren
APA
Khasanov, U., Matmuratov, Z. S., Coman, A., Buruiană, A. M., Passali, D., Passali, F. M., & DeRowe, A. (2026). Irreversible Electroporation for the Treatment of Pediatric Adenotonsillar Hypertrophy. Journal of Clinical Medicine, 15(13), 5189. https://doi.org/10.3390/jcm15135189
Vancouver
Khasanov U, Matmuratov ZS, Coman A, Buruiană AM, Passali D, Passali FM, et al. Irreversible Electroporation for the Treatment of Pediatric Adenotonsillar Hypertrophy. Journal of Clinical Medicine. 2026;15(13):5189. doi:10.3390/jcm15135189
BibTeX
@article{Khasanov2026,
author = {Khasanov, Ulugbek and Matmuratov, Zukhrob Sobirjonovich and Coman, Alexandru and Buruiană, Andrei Mihai and Passali, Desiderio and Passali, Francesco Maria and DeRowe, Ari},
title = {Irreversible Electroporation for the Treatment of Pediatric Adenotonsillar Hypertrophy},
journal = {Journal of Clinical Medicine},
year = {2026},
volume = {15},
number = {13},
pages = {5189},
doi = {10.3390/jcm15135189}
}
EUVIMED